Overview

The Effect of Solifenacin on Post Void Dribbling in Women

Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
This is a double-blind, randomized, controlled, parallel design (n=140) study with the purpose of measuring the efficacy of Solifenacin 5mg in the treatment of women with Post Void Dribbling.
Phase:
N/A
Details
Lead Sponsor:
University of Wisconsin, Madison
Treatments:
Solifenacin Succinate